Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse
Released on J-STAGE: December 14, 2019 |
Volume 40
Issue 6
Pages 243-250
Tadashi ASHIZAWA, Akira IIZUKA, Emiko TANAKA, Ryota KONDOU, Haruo MIYATA, Chie MAEDA, Takashi SUGINO, Ken YAMAGUCHI, Takayuki ANDO, Yoshinobu ISHIKAWA, Mamoru ITO, Yasuto AKIYAMA